A program to improve diabetes management for Latinx patients using technology and behavioral economics
Official title: DM-BOOST Para Latinx: a Diabetes Mellitus Program Using Behavioral Economics to Optimize Outreach and Self-management Support With Technology for Latinx Patients
Run by University of Massachusetts, Worcester · NCT05583877 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a new program that uses technology and behavioral strategies to help Latinx patients with type 2 diabetes manage their condition better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | University of Massachusetts, Worcester Academic / other |
| Locations | 2 sites (Worcester, Massachusetts and 1 other locations) |
| Trial ID | NCT05583877 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are Hispanic/Latinx individuals over 18 years old who have been diagnosed with type 2 diabetes and prefer to communicate in Spanish.
✕Probably not a fit
Patients with cognitive impairments, current prisoners, pregnant women, or those who have completed diabetes self-management training in the past year may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to culturally adapt the DM-BOOST intervention specifically for Latinx patients with type 2 diabetes. It will involve usability testing to ensure the program is culturally appropriate and engaging for participants. The study will utilize a community-based participatory research approach, collaborating with clinical, community, and patient partners to enhance outreach and self-management support. The findings will inform future proposals for implementing the DM-BOOST program within the UMass Memorial Health Care system.
Why it matters
Potential benefit: If successful, this program could significantly improve diabetes management and health outcomes for Latinx patients.
How similar studies have gone: Other studies have shown success in using culturally tailored interventions for diabetes management, indicating a promising approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Aims 1 and 2 Patient Inclusion Criteria: * Age \> 18 years * Diagnosis of type 2 diabetes * Identifies as Hispanic/Latinx * Spanish language preference Aims 1 and 2 Patient Exclusion Criteria: * Cognitive impairment * Current prisoner * Pregnant women Aim 3 Patient Inclusion Criteria: * Age \> 18 years * Diagnosis of type 2 diabetes * Identifies as Hispanic/Latinx * Spanish language preference Aim 3 Patient Exclusion Criteria: * Cognitive impairment * Current prisoner * Pregnant women * Completed DSMT in previous year
Where it's running
-
UMass Memorial health
Worcester, Massachusetts, United States Recruiting -
University of Massachusetts Medical School
Worcester, Massachusetts, United States Not yet recruiting
Study contacts
- Principal investigator: Daniel J Amante, PhD, MPH — UMass Chan Medical School
- Study coordinator: Daniel J Amante, PhD, MPH
- Email: daniel.amante@umassmed.edu
- Phone: 508-856-8480
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Proliverenol for liver fat and insulin resistance in type 2 diabetes
This study tests whether adding Proliverenol to standard diabetes care can improve liver fat and blood sugar control in adults with type 2 diabetes.
-
Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes
This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.
-
Safety test of NNC9836-0001 in adults with overweight/obesity or type 2 diabetes
This study tests whether the new medicine NNC9836-0001 is safe and tolerable in adults who are overweight or have type 2 diabetes, compared to placebo.
-
RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes
This study tests the accuracy and safety of the RIGHTEST iFree 2 continuous glucose monitor in pregnant adults with type 1, type 2, or gestational diabetes.
-
EloraTZP for weight loss in adults with overweight/obesity and type 2 diabetes
This trial tests whether a coformulation of eloralintide and tirzepatide helps people with obesity or overweight and type 2 diabetes lose weight compared with tirzepatide alone.
-
Maridebart cafraglutide vs. semaglutide for type 2 diabetes on metformin
This trial tests whether maridebart cafraglutlide is as good as semaglutide at improving blood sugar in adults with type 2 diabetes who take metformin (with or without an SGLT-2 inhibitor).
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.